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Abstract 
   It has been known that several genes have been linked to human cancers 
especially that encode PR domain-containing transcriptional regulator. Particularly 
PRDM14, which is found to be critical for specification of germ cell fate, PRDM14 is 
expressed in proximal after embryonic day (E) 6.5. PRDM14 is expressed not only in 
PGCs but also in inner cell mass (ICM) and ESCs in normal condition. It has been 
shown that PRDM14 is overexpressed in breast cancer cell and tissues associated with 
gene amplification. Moreover, it has been shown that highly expressed PRDM14 
promotes anchorage-independent growth and resistance for chemotherapy in breast 
cancer. However, it has been largely unknown the mechanism of tumor malignancy by 
overexpression of PRDM14. We previously have provided evidence that PRDM14 
promotes active DNA demethylation through Ten-eleven translocation (TET)-mediated 
base excision repair pathway. To investigate molecular mechanisms of PRDM14 in 
breast cancer progression, I have tried to establish PRDM14 knockdown (KD) and 
knockout (KO) breast cancer cell line using by lentivirus system and   CRISPR/Cas9 
system. Furthermore, I have tried to detect the interaction between PRDM14 and TET2 
in MCF7 carrying doxycycline-inducible the expression of PRDM14. 
